Skip to main content
SpringerLink
Log in

Growth in the drugs to treat Crohn's disease market is being hampered by considerable reimbursement limitations on biological agents,

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources.Reimbursement Limitations on Biologic Agents Are Constraining Growth in the Crohn's Disease Drug Market. Media Release: 30 Jan 2007. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Growth in the drugs to treat Crohn's disease market is being hampered by considerable reimbursement limitations on biological agents,. Pharmacoecon. Outcomes News 521, 10 (2007). https://doi.org/10.2165/00151234-200705210-00037

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705210-00037

Keywords

Search

Navigation